Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BOLD: Blood Pressure Lowering in Dialysis
NCT03459807Phase 2Completed
- Sponsor
- University of California, San Francisco
- Start
- Mar 2018
- Primary completion
- Dec 2018
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial (2 arms), sponsored by University of California, San Francisco. Primary endpoints: Feasibility - Screen:Enrollment Ratio, Adherence to Assigned Treatment Arm at 4 months and 2 more. Started Mar 2018; status: completed.
Beyond the preview
Go deeper on NCT03459807.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03459807.